Key statistics
As of last trade Immutep Ltd (IMMP:NMQ) traded at 2.73, -22.66% below its 52-week high of 3.53, set on Dec 08, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.78 |
|---|---|
| High | 2.86 |
| Low | 2.63 |
| Bid | 2.72 |
| Offer | 2.73 |
| Previous close | 2.80 |
| Average volume | 190.51k |
|---|---|
| Shares outstanding | 147.37m |
| Free float | 122.43m |
| P/E (TTM) | -- |
| Market cap | 403.07m USD |
| EPS (TTM) | -0.4074 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 17:27 GMT.
More ▼
- Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa
- Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer
- Immutep’s Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer
